FDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Sarcoma & GISTPatient & Survivor CareCNS/Brain CancerNeuro-oncologyNonmelanoma Skin CancerMetastatic Breast CancerPractice Management
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer CareAugust 2, 2024Patient & Survivor CarePractice ManagementGastrointestinal CancerGastroenterologyGenitourinary CancerGynecologic CancerBreast Cancer
Ancient Viruses in Our DNA Hold Clues to Cancer TreatmentAugust 2, 2024Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterology
Outcomes with CDK4/6 Inhibitors Vary in BCJuly 30, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Which Patients With Early TNBC Can Avoid Chemotherapy?July 29, 2024Breast CancerPatient & Survivor Care
Black Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024ASCO Breast CancerBreast CancerDiversity in Medicine
Greater Transparency of Oncologists’ Pharma Relationships NeededJuly 22, 2024Practice ManagementPatient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLDiversity in Medicine
Could an EHR Nudge Reduce Unnecessary Biopsies?July 18, 2024Breast CancerPatient & Survivor CarePreventive CarePractice Management
Cognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Eribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareASCO Breast Cancer
PFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
New Canadian BC Guidelines Emphasize Personal ChoiceJuly 10, 2024Breast CancerPatient & Survivor CarePreventive Care
Should Cancer Trial Eligibility Become More Inclusive?July 10, 2024Practice ManagementPatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
